ES8104245A1 - Procedimiento para la preparacion de derivados de bencimida-zol - Google Patents

Procedimiento para la preparacion de derivados de bencimida-zol

Info

Publication number
ES8104245A1
ES8104245A1 ES491143A ES491143A ES8104245A1 ES 8104245 A1 ES8104245 A1 ES 8104245A1 ES 491143 A ES491143 A ES 491143A ES 491143 A ES491143 A ES 491143A ES 8104245 A1 ES8104245 A1 ES 8104245A1
Authority
ES
Spain
Prior art keywords
linear
ramified
radicals
radical
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES491143A
Other languages
English (en)
Other versions
ES491143A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Continental Pharma Inc
Original Assignee
Continental Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Continental Pharma Inc filed Critical Continental Pharma Inc
Publication of ES8104245A1 publication Critical patent/ES8104245A1/es
Publication of ES491143A0 publication Critical patent/ES491143A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE BENCIMIDAZOL, DE FORMULA GENERAL (I), DONDE R1 PUEDE SER DISTINTOS TIPOS DE RADICALES; R2 Y R3 PUEDEN SER HIDROGENO O DISTINTOS TIPOS DE RADICALES. CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II), DONE B Y Q REPRESENTAN DISTINTOS RADICALES, CON UN COMPUESTO DE FORMULA R1Z'', DONDE Z'' PUEDE SER DISTINTOS TIPOS DE RADICALES. ESTOS PRODUCTOS SE APLICAN PARA LA PROFILAXIS Y TRATAMIENTO DE LA HIPERTENSION Y AFECCIONES CARDIOVASCULARES. *FORMULA*
ES491143A 1979-05-04 1980-05-02 Procedimiento para la preparacion de derivados de bencimida-zol Granted ES491143A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU81225 1979-05-04

Publications (2)

Publication Number Publication Date
ES8104245A1 true ES8104245A1 (es) 1981-04-16
ES491143A0 ES491143A0 (es) 1981-04-16

Family

ID=19729148

Family Applications (2)

Application Number Title Priority Date Filing Date
ES491143A Granted ES491143A0 (es) 1979-05-04 1980-05-02 Procedimiento para la preparacion de derivados de bencimida-zol
ES491142A Granted ES491142A0 (es) 1979-05-04 1980-05-02 Procedimiento para la preparacion de derivados de fenileti- lamina

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES491142A Granted ES491142A0 (es) 1979-05-04 1980-05-02 Procedimiento para la preparacion de derivados de fenileti- lamina

Country Status (22)

Country Link
US (1) US4338330A (es)
JP (2) JPS6033424B2 (es)
AT (2) AT376418B (es)
AU (2) AU542596B2 (es)
BE (2) BE883069A (es)
CA (1) CA1146563A (es)
CH (2) CH644599A5 (es)
DE (2) DE3016828A1 (es)
DK (2) DK187980A (es)
ES (2) ES491143A0 (es)
FI (2) FI801428A (es)
FR (2) FR2455572B1 (es)
GB (2) GB2055360B (es)
GR (2) GR68535B (es)
IE (1) IE50218B1 (es)
IL (2) IL59973A (es)
IT (2) IT1150018B (es)
NL (2) NL8002567A (es)
NO (2) NO150916C (es)
PT (2) PT71174A (es)
SE (2) SE8003278L (es)
ZA (2) ZA802694B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1156661A (en) * 1980-02-25 1983-11-08 Hoffmann-La Roche Limited Phenoxy-aminopropanol derivatives
JPS582343A (ja) * 1981-06-30 1983-01-07 Osaka Soda Co Ltd 耐窒素酸化物性に優れた加硫性ゴム組成物
GB8310556D0 (en) * 1983-04-19 1983-05-25 Beecham Group Plc Compounds
US4550119A (en) * 1983-05-23 1985-10-29 Warner-Lambert Company 2,4-Dihydro-5-[(substituted)phenyl]-4,4-disubstituted-3H-pyrazol-3-ones
US5104892A (en) * 1989-12-11 1992-04-14 American Home Products Corporation Substituted benzimidazole derivatives possessing Class III antiarrhythmic activity
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
JP2005520858A (ja) 2002-03-20 2005-07-14 メタボレックス, インコーポレイテッド 置換フェニル酢酸
US7351719B2 (en) 2002-10-31 2008-04-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
US7199259B2 (en) * 2003-06-20 2007-04-03 Metabolex, Inc. Resolution of α-(phenoxy)phenylacetic acid derivatives
RU2006145872A (ru) * 2004-05-25 2008-06-27 Метаболекс, Инк. (Us) Замещенные триазолы в качестве модуляторов ppar и способы их получения
EP1749000A4 (en) * 2004-05-25 2009-12-30 Metabolex Inc BICYCLIC SUBSTITUTED TRIAZOLE AS PPAR MODULATORS AND METHOD FOR THE PRODUCTION THEREOF
US7714131B2 (en) * 2005-09-23 2010-05-11 Metabolex, Inc. Process for the stereoselective preparation of (−)-halofenate and derivatives thereof
EP2727911B1 (en) * 2012-10-31 2016-12-21 Medizinische Hochschule Hannover Novel means and methods for treating malaria and other parasitic disorders

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1157556A (en) * 1966-06-09 1969-07-09 Egyt Gyogyszervegyeszeti Gyar Novel Benzazole Derivatives and the Preparation thereof
FR1570892A (es) 1968-06-18 1969-06-13
US3574218A (en) * 1969-08-11 1971-04-06 Egyt Gyogyszervegyeszeti Gyar 2-aryl- or aralkyl-substituted benzazole derivatives
JPS5231858B1 (es) * 1969-12-17 1977-08-17
CH624395A5 (es) 1976-01-08 1981-07-31 Ciba Geigy Ag
DE2609645A1 (de) 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
DE2640730C2 (de) * 1976-09-10 1983-08-25 Hoechst Ag, 6230 Frankfurt Benzoxazolyloxy- und Benzothiazolyloxy-phenoxy-Verbindungen und diese enthaltende herbizide Mittel
DE2644833A1 (de) * 1976-10-05 1978-04-20 Boehringer Sohn Ingelheim Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung
DE2737630A1 (de) 1977-08-20 1979-03-01 Boehringer Mannheim Gmbh Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2801953A1 (de) 1978-01-18 1979-07-19 Boehringer Mannheim Gmbh 4-hydroxy-2-benzimidazolinon-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE2801980A1 (de) 1978-01-18 1979-07-19 Boehringer Mannheim Gmbh 4-hydroxy-2-benzimidazolin-thion- derivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
EP0003758A1 (de) 1978-02-09 1979-09-05 Ciba-Geigy Ag Verätherte Hydroxy-benzodiheterocyclen und ihre Säureadditionssalze, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE2905877A1 (de) 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2905876A1 (de) 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh Neue piperidinopropylderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
SE8003277L (sv) 1980-11-05
ZA802695B (en) 1981-08-26
FR2455572B1 (fr) 1986-07-25
IT8021779A0 (it) 1980-05-02
FI801429A (fi) 1980-11-05
CH645090A5 (fr) 1984-09-14
GB2055091A (en) 1981-02-25
ATA238680A (de) 1984-04-15
NL8002567A (nl) 1980-11-06
GB2055360B (en) 1983-07-06
GR68535B (es) 1982-01-18
IT1159060B (it) 1987-02-25
IL59974A0 (en) 1980-07-31
IE800918L (en) 1980-11-04
AU5809680A (en) 1980-11-06
FR2455572A1 (fr) 1980-11-28
CH644599A5 (fr) 1984-08-15
ATA238780A (de) 1984-03-15
BE883068A (fr) 1980-08-18
AU537573B2 (en) 1984-07-05
DE3016828A1 (de) 1980-11-13
AU542596B2 (en) 1985-02-28
NL8002568A (nl) 1980-11-06
JPS6033424B2 (ja) 1985-08-02
AT376210B (de) 1984-10-25
IT8021780A0 (it) 1980-05-02
SE8003278L (sv) 1980-11-05
GB2055091B (en) 1983-11-09
DK187880A (da) 1980-11-05
ES8103729A1 (es) 1981-03-16
JPS5663946A (en) 1981-05-30
PT71174A (fr) 1980-05-01
IT8021780A1 (it) 1981-11-02
IE50218B1 (en) 1986-03-05
NO150916B (no) 1984-10-01
US4338330A (en) 1982-07-06
NO801285L (no) 1980-11-05
IT1150018B (it) 1986-12-10
IL59973A0 (en) 1980-07-31
NO801286L (no) 1980-11-05
JPS565465A (en) 1981-01-20
CA1146563A (en) 1983-05-17
NO150916C (no) 1985-01-16
ZA802694B (en) 1981-08-26
ES491143A0 (es) 1981-04-16
FR2455587A1 (fr) 1980-11-28
AU5809580A (en) 1980-11-06
BE883069A (fr) 1980-08-18
ES491142A0 (es) 1981-03-16
FR2455587B1 (es) 1983-06-24
FI801428A (fi) 1980-11-05
GB2055360A (en) 1981-03-04
IT8021779A1 (it) 1981-11-02
GR68536B (es) 1982-01-18
IL59973A (en) 1985-03-31
DE3016827A1 (de) 1980-11-20
AT376418B (de) 1984-11-26
PT71175A (fr) 1980-05-01
DK187980A (da) 1980-11-05

Similar Documents

Publication Publication Date Title
ES8104245A1 (es) Procedimiento para la preparacion de derivados de bencimida-zol
ES2094309T3 (es) Esteres de acidos grasos de acido isetionico alcoxilado y composiciones detergentes que comprenden los mismos.
IE800599L (en) Derivatives of glycinamide
ES2179823T3 (es) Inmunosupresor macrolido.
ES505960A0 (es) Un procedimiento para la obtencion de un derivado acilico sustituido del compuesto acido 1,2,3,4-tetrahidro-3-isoqui- nolein-carboxilico
PT96890A (pt) Processo para a preparacao de novos derivados com estrutura naftalenica e de composicoes farmaceuticas que os contem
KR940014293A (ko) 아이오드화 아로일옥시 에스테르
KR830006174A (ko) 기관지 항경련성 화합물 제조방법
PL298127A1 (en) Method of obtaining 13,14-dihydro-15(r)-phenyl-18,19,20-trinor-pgf down 2alpha isopropyl ester
SE8106125L (sv) 4,5-polymetylen-4-isotiazolin-3-oner, sett for framstellning derav och anvendning derav som baktericida och fungicida medel
EA199801000A1 (ru) Производные алкиламинобензотиазола и -бензоксазола
KR930703336A (ko) 신규한 메틸렌비스포스폰산 유도체
SE7610038L (sv) Miticida och aficida karboxylsyraestrar
ES484553A1 (es) Un metodo para preparar 4-fenil-1,3-benzodiazepinas
ES2155621T3 (es) Derivados azo del acido 5-aminosalicilico para el tratamiento de la enfermedad inflamatoria intestinal.
FI812804L (fi) 2-(1,4-bensodioxan-2-ylalkyl)-imidazoler anvaendbara som antidepressiva laekemedel
KR900011770A (ko) 신규 벤조 [1,8] 나프티리딘 유도체, 그 제조방법 및 상기 유도체를 함유하는 조성물
FI932596A (fi) 7-substituerad-6-fluor-1,4-dihydro-oxokinolin-3-karboxylsyrafoereningar anvaendbara som antibakteriska aemnen
IL67088A (en) Carboxyalkyl esters of polysubstituted benzoic and phenylacetic acids and their use as plant growth regulating agents
ES8203870A1 (es) Procedimiento para preparar difenilbutil-1-acilpiperazinas
HUP9903526A2 (hu) Pirimidinszármazékok és az ezeket tartalmazó gyógyszerkészítmények
PE130099A1 (es) Nuevos derivados de la equinocandina, su procedimiento de preparacion y su aplicacion como fungicidas
ES476354A1 (es) Procedimientos para la obtencion de nuevos derivados de ari-laminoimidazolina.
FI972189A0 (fi) Halogenoidut esterit, jotka ovat käyttökelpoisia välituotteina hyönteismyrkkyjen valmistamiseksi
DE3060945D1 (en) Silyl-benzimidazole-carbamic acid esters, process for their preparation and their use as fungicides